SIRT1 and metabolic dysfunction-associated steatotic liver disease: In addition, SIRT1 deacetylates QKI-5 protein, which inhibits NAFLD development in mice, due to inhibition of triglyceride synthesis through modulation PPAR-gamma- and FoxO1-dependent signaling (Zhang et al., 2019).